Testing effectiveness (Phase 2)Looking for participantsNCT06195306
What this trial is testing
Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction
Who this might be right for
Breast Atypical HyperplasiaBreast CarcinomaBreast Ductal Carcinoma In Situ+1 more
National Cancer Institute (NCI) 66